Stay updated with breaking news from Nasdaq trvn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Trevena, Inc. (NASDAQ:TRVN – Get Free Report) was the recipient of a significant drop in short interest in December. As of December 15th, there was short interest totalling 286,800 shares, a drop of 41.8% from the November 30th total of 493,000 shares. Based on an average daily volume of 334,300 shares, the short-interest ratio is […] ....
StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN – Free Report) in a report issued on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Trevena Trading Down 1.4 % Shares of NASDAQ:TRVN opened at $0.71 on Friday. Trevena has a 12-month low of $0.51 and a 12-month high of $3.28. The […] ....
CHESTERBROOK, Pa., Dec. 27, 2023 (GLOBE NEWSWIRE) Trevena Inc. (“Trevena” or the “Company”) (Nasdaq: TRVN), a biopharmaceutical company focused on the. ....
StockNews.com assumed coverage on shares of Trevena (NASDAQ:TRVN – Free Report) in a report published on Saturday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Trevena Stock Performance Shares of TRVN stock opened at $0.65 on Friday. The stock has a fifty day moving average of $0.58 and a 200 day moving […] ....
StockNews.com started coverage on shares of Trevena (NASDAQ:TRVN – Free Report) in a research note published on Friday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Trevena Stock Performance Shares of TRVN stock opened at $0.60 on Friday. The firm has a market cap of $9.10 million, a price-to-earnings ratio of -0.21 […] ....